Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $38.1900 (2.91%) ($37.1500 - $38.6100) on Wed. Apr. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.75% (three month average) | RSI | 70 | Latest Price | $38.1900(2.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.8% a day on average for past five trading days. | Weekly Trend | EDIT advances 9.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(60%) IBB(59%) XBI(58%) IWO(55%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -4.375% in a week (0% probabilities). VIXM(-14%) TLT(-7%) SHY(-6%) GDXJ(-5%) IPO(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.375% (StdDev 8.75%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $38.7(-1.32%) | 10 Day Moving Average | $38.86(-1.72%) | 20 Day Moving Average | $34.99(9.15%) | To recent high | -9.2% | To recent low | 198.1% | Market Cap | $2.372b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |